Blueprint Medicines Corp (NASDAQ:BPMC)

66.98
Delayed Data
As of Feb 14
 +3.17 / +4.97%
Today’s Change
60.60
Today|||52-Week Range
102.98
-16.39%
Year-to-Date
About to Buy Penny Stocks? Look at These 2 Companies First
Feb 14 / MotleyFool.com - Paid Partner Content
Blueprint Medicines (BPMC) Q4 2019 Earnings Call Transcript
Feb 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close63.81
Today’s open63.47
Day’s range63.21 - 67.24
Volume568,779
Average volume (3 months)634,511
Market cap$3.6B
Data as of 4:00pm ET, 02/14/2020

Growth & Valuation

Earnings growth (last year)-34.76%
Earnings growth (this year)-20.40%
Earnings growth (next 5 years)+23.32%
Revenue growth (last year)+49.39%
P/E ratioNM
Price/Sales57.61
Price/Book7.11

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...+0.24+0.76%
IMMUImmunomedics Inc-0.40-2.13%
CRSPCRISPR Therapeutics ...-2.32-3.99%
AXSMAxsome Therapeutics ...+1.80+2.03%
Data as of 4:00pm ET, 02/14/2020

Financials

Next reporting dateMay 6, 2020
EPS forecast (this quarter)-$2.16
Annual revenue (last year)$66.5M
Annual profit (last year)-$347.7M
Net profit margin-522.75%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts